MET and neoplasm: Current studies have presented two mechanisms on the anti-tumor capacity of decorin, of which one is directly inhibiting the signal transduction pathways in tumor cells via interaction with two receptor tyrosine kinases, Met and EGFR (9, 10), and the other is inducing autophagy to reduce the metastasis and spread of cancer cells (11).